Kapanol TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: morphine
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 20 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain: KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness: KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 4, natural cap & natural body, printed with 'K20' in black on cap and 2 discontinuous black bands on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 28 and 60 capsules pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 50 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 2, natural cap & natural body, printed with 'K50' in black on cap and 3 discontinuous black bands on the body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 28 and 60 capsules pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 100 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, Size 0, with natural cap & natural body, with 'K100' in black on cap and 4 discontinuous black bands on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 60 capsules pack
- 28 capsules pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 4, natural cap & natural body, printed K10 in black on cap & discontinuous black band printed on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20 capsules pack
- 28 capsules pack
- 60 capsules pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 20 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain: KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness: KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 4, natural cap & natural body, printed with 'K20' in black on cap and 2 discontinuous black bands on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 28 and 60 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 20 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain: KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness: KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 4, natural cap & natural body, printed with 'K20' in black on cap and 2 discontinuous black bands on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 28 and 60 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 50 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 2, natural cap & natural body, printed with 'K50' in black on cap and 3 discontinuous black bands on the body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 28 and 60 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 50 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 2, natural cap & natural body, printed with 'K50' in black on cap and 3 discontinuous black bands on the body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 28 and 60 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 100 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, Size 0, with natural cap & natural body, with 'K100' in black on cap and 4 discontinuous black bands on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 60 capsules pack
- 28 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 100 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, Size 0, with natural cap & natural body, with 'K100' in black on cap and 4 discontinuous black bands on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20, 60 capsules pack
- 28 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 4, natural cap & natural body, printed K10 in black on cap & discontinuous black band printed on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20 capsules pack
- 28 capsules pack
- 60 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: KAPANOL morphine sulfate pentahydrate 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Management of Severe Pain KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, modified release
- Oral
- Hard gelatin caps, size 4, natural cap & natural body, printed K10 in black on cap & discontinuous black band printed on body, containing creamy-white to light tan spheroidal pellets.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
- 20 capsules pack
- 28 capsules pack
- 60 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
